Abstract:Owa and Owa inquired about the serologic tests of the 3 neonates and the treatment of neonates with COVID-19.The serologic tests for SARS-CoV-2 were not available until the end of February 2020.Currently, only 6 infected neonates have been reported in China.Four mildly infected neonates improved with primary care.Of 2 critical cases in China, 1 was the third patient in our article, and another neonate with congenital heart disease (6.9-mm atrial septal defect) presented with pneumonia and cardiac insufficiency.The neonate improved rapidly with antibiotics, inotropic therapy, and fluid management.None of the infected neonates received antiviral therapy.Verd et al raised the issue of whether mothers with COVID-19 should continue breastfeeding.Viral nucleic acid for SARS-CoV-2 has not been detected in breast milk thus far.However, the neonates born to an affected mother are at great risk of COVID-19 owing to close contact and should be separated from mothers and fed by formula initially.As our protocol suggested, the isolated mothers should keep pumping to maintain breast milk. 3 Considering the virus may be excreted into the milk during the incubation period, donor milk and breast milk can be considered for use after being screened for SARS-CoV-2. 3 Mimouni et al questioned the criteria used to diagnose COVID-19 pneumonia.In our study, 3 neonates with COVID-19 had not been reported in other cohorts before publication.Patients 1 and 2 were born February 3, 2020, and February 5, 2020, respectively.Patient 1 was admitted to the neonatal intensive care unit owing to lethargy and fever (37.6 °C) at day 3 of life (February 5, 2020).His procalcitonin level (PCT) was 0.090 ng/mL (normal range, ≤0.05 ng/mL).Patient 2 experienced lethargy, vomiting, and fever (37.7 °C), and laboratory test results showed leukocytosis, lymphocytopenia, and an elevated creatine kinase myocardial band.Although no respiratory symptoms were observed and chest images showed infiltrates, the 2 neonates were diagnosed as having symptomatic neonatal COVID-19 based on the exposure history and positive SARS-CoV-2 test result. 3,4 Currently, less than 10 confirmed neonatal cases have been reported.Therefore, the full clinical picture of neonatal COVID-19 remains uncertain.Hijikata et al, Abu Raya et al, and Vecchio pointed out that the serial serologic tests were helpful to diagnose congenital COVID-19.We do agree that viral or serologic test results cannot confirm the intrauterine SARS-CoV-2 infection.However, at the early phase of the COVID-19 epidemic in China, the testing methods for SARS-CoV-2 were limited.Initially, real-time fluorescence PCR was only available for SARS-CoV-2 using nasopharyngeal and oropharyngeal specimens.At present, both serological testing and RT-PCR can be performed; yet, no more neonates with early-onset COVID-19 have been identified with the control of the COVID-19 epidemic in China.We are concerned about the neurologic outcomes of neonates with COVID-19 or born to infected mothers.The study from Zhu et al 5 has shown that 2 newborns presented with elevated PCT levels and interleukin 6 with 72 hours of life (interleukin 6, 274.6 pg/mL and PCT, 9.2 ng/mL in newborn 3; and PCT, 20.74 pg/mL in newborn 4); 1 died of multiple organ failure.These elevated inflammatory markers may be associated with the maternal COVID-19.Therefore, the infants with COVID-19 or born to affected mothers have been followed up in our clinic.

Disappearance of SARS-CoV-2 Antibodies in Infants Born to Women with COVID-19, Wuhan, China

Detectable Antibodies Against SARS-CoV-2 in Newborns from Mothers Infected with COVID-19 at Different Gestational Ages

Dynamic Changes of Acquired Maternal SARS-CoV-2 IgG in Infants.

Antibodies in Infants Born to Mothers with COVID-19 Pneumonia.

The Immunologic Status of Newborns Born to SARS-CoV-2–infected Mothers in Wuhan, China

SARS-CoV-2 Infection in Infants under 1 Year of Age in Wuhan City, China.

Possible intrauterine SARS-CoV-2 infection: Positive nucleic acid testing results and consecutive positive SARS-CoV-2-specific antibody levels within 50 days after birth

Retrospective Analysis of Clinical Characteristics and Neonatal Outcomes of Pregnant Women with SARS-COV-2 Infection

Maternal SARS-CoV-2 IgG provides limited protection for their infants

Dynamic Characteristic Analysis of Antibodies in Patients with COVID-19: A 13-Month Study

Clinical Analysis of Neonates Born to Mothers with or without COVID-19: A Retrospective Analysis of 48 Cases from Two Neonatal Intensive Care Units in Hubei Province

Analysis of Epidemiological and Clinical Characteristics of Children with Mild COVID-19 and Discussion on the Clinical Significance of SARS-CoV-2 Antibody

Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.

Transplacental transmission of SARS‐CoV‐2 immunoglobulin G antibody to infants from maternal COVID‐19 vaccine immunization before pregnancy

Epidemiological and Clinical Characteristics of Children with Mild COVID-19 and Clinical Significance of SARS-CoV-2 Antibody

Error in the Abstract and Results Section

Novel coronavirus infection in newborn babies aged <28 days in China.

Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection During Pregnancy in China: A Retrospective Cohort Study

Clinical Characteristics and Risk Assessment of Newborns Born to Mothers with COVID-19.

Shadow of a Pandemic: Persistence of Prenatal SARS-CoV-2 Antibodies in Newborn Blood Spots

Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity